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Inhibitors of cyclin-dependent kinases induce features of
replicative senescence in early passage human diploid fibroblasts
Beth B. McConnell, Maria Starborg, Sharon Brookes and Gordon Peters
After a limited number of population doublings (PDs),
cultures of normal mammalian diploid cells undergo an
irreversible growth arrest known as replicative
senescence [1]. As well as contributing to cellular
ageing, senescence is viewed as an important
mechanism of tumour suppression by preventing the
emergence of immortal cell clones [2–4]. Senescent
cells have a number of characteristics that distinguish
them from cycling or quiescent cells including elevated
levels of two cyclin-dependent kinase (Cdk) inhibitors,
p16INK4a and p21CIP1 [5–11]. Here, we demonstrate that
both of these Cdk inhibitors, as well as other members
of their protein families (the INK4 and CIP/KIP families,
respectively [12]), induce several facets of the
senescent phenotype when ectopically expressed in
young human diploid fibroblasts. These include a
reduced proliferative capacity, an altered size and
shape, the presence of underphosphorylated
retinoblastoma protein (pRb), increased expression of
plasminogen activator inhibitor (PAI-1) and the
appearance of senescence-associated b-galactosidase
(SA-b-gal) activity [2,3,13–15]. A 20 amino acid peptide
from p16INK4a that inhibits Cdks active in the G1 phase
of the cell cycle [16] produces similar effects in a dose-
dependent manner suggesting that, in primary
fibroblasts, inhibition of G1-specific Cdk activity is
sufficient to induce phenotypic changes that normally
occur at the end of their finite lifespan.
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Results and discussion
TIG-3 strain human diploid fibroblasts, which typically
undergo 60 to 70 PDs in tissue culture, were infected at PD
40–44 with recombinant retroviruses encoding different
Cdk inhibitors (see Materials and methods). These
included p21CIP1 and p27KIP1, which interact with multiple
cyclin–Cdk complexes, plus p16INK4a and p15INK4b, two
members of the INK4 family which specifically inhibit the
cyclin-D-dependent kinases Cdk4 and Cdk6 (reviewed in
[12]). Retroviruses based on the pBABE-puro or pBABE-
hygro vectors [17] allowed selection of transduced cells
within 4 to 6 days and infection efficiencies were between
50% and 75% as judged by the percentage of cells surviving
Figure 1
Growth arrest of human diploid fibroblasts by ectopic expression of
Cdk inhibitors. (a) Lysates were prepared from TIG-3 cells (PD 40–44)
6 or 12 days after infection with recombinant retroviruses encoding
p15INK4b, p16INK4a, p21CIP1 or p27KIP1 and the level of the expressed
Cdk inhibitor in each lysate was compared to those present in cells
infected with the empty vector control (Vector) and from TIG-3 cells
that had reached the end of their finite lifespan (~65 PD; Senescent).
Equivalent amounts of cellular proteins were fractionated by gel
electrophoresis and analysed by immunoblotting [21] with primary
antibodies against p15INK4b (Santa Cruz #sc-612), p16INK4a (DCS-
50), p21CIP1 (Santa Cruz #sc-397) and p27KIP1 (Santa Cruz #sc-
528). (b) Cells were plated at 1 × 104 cells per well, in a 24-well plate,
and at 6, 9 and 12 days after infection with the same retroviruses as in
(a), triplicate wells were fixed and stained with 10% formalin and 0.1%
crystal violet. The intracellular stain was eluted with 10% acetic acid
and relative cell numbers determined by measuring the optical density
of the eluates at 590 nm [15]. The results shown were derived from
two separate experiments. (c) Immunoblotting for pRb (using the
Pharmingen G3-245 antibody) was performed on lysates made six
days after infection with the indicated retroviruses. The
hyperphosphorylated form of pRb is indicated as ppRb. (d) Cells were
labelled with 10 µM bromodeoxyuridine (BrdU; Amersham) for 4 h
6 days after infection with the indicated retroviruses, stained with
fluorescein isothiocyanate (FITC)-conjugated anti-BrdU antibody and
analysed by two-dimensional flow cytometry.
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selection. Expression of p15INK4b, p16INK4a, p21CIP1, and
p27KIP1 was monitored by immunoblotting cell lysates
taken at 6 and 12 days post-infection. The levels of ectopic
expression were compared with the endogenous levels
present in cells transduced with the empty vector and in
TIG-3 cells that had reached the end of their finite lifespan
(Figure 1a). In each case, ectopic expression of the Cdk
inhibitor was at least 10-fold higher than in the vector-only
controls and cells infected with the p16INK4a or p21CIP1
viruses were producing amounts of protein roughly equiva-
lent to those found in senescent cells.
As judged by cell proliferation assays, cells expressing the
Cdk inhibitors had a significantly lower rate of division
than cells transduced with the empty vector (Figure 1b).
Fibroblasts expressing INK4 inhibitors were more effec-
tively arrested than those expressing CIP/KIP proteins
(Figure 1b) with p15INK4b causing complete growth arrest
over the timescale of the experiment. Similarly, whereas
pRb was predominantly in its hyperphosphorylated state
in proliferating control cells, judged by its mobility in
sodium dodecyl sulphate (SDS)-containing acrylamide
gels, the Cdk inhibitors caused accumulation of the more
rapidly migrating, underphosphorylated form (Figure 1c).
Again, the INK4 proteins had a more pronounced effect
than the CIP/KIP proteins. The same trend was noted in
bromodeoxyuridine (BrdU) incorporation assays: only 3%
of the cells expressing p15INK4b or p16INK4a were able to
enter the DNA synthesis (S) phase of the cell cycle during
the 4 hour labelling period compared with 15% and 8% of
the cells expressing p21CIP1 and p27KIP1, respectively
(Figure 1d). These differences in the extent to which cells
were arrested by the Cdk inhibitors could be attributable
to different levels of expression within the pools of
infected cells or to differences in the molar concentration
of each protein required to fully block G1 Cdk activity.
As well as being growth arrested, the majority of the
infected cells were enlarged and flattened in appearance
(data not shown). Such morphological changes, which are
often associated with senescence [2–4], were noticeable
within 6 days of infection and persisted. The cells also had
increased expression of the mRNA for PAI-1, which is
involved in regulating the turnover of extracellular matrix
proteins (Figure 2a). Levels of expression of the two PAI-1
mRNA transcripts, and in particular the smaller of the two,
have been shown to be higher in senescent cells [13,15].
The amounts of the smaller PAI-1 transcript were 3–4-fold
higher in cells expressing the Cdk inhibitors than in vector-
only controls and approached those found in newly senes-
cent TIG-3 cells (Figure 2a). Infected cells were also tested
for expression of SA-β-gal activity, a convenient marker that
can distinguish between cells arrested in a senescent versus
a quiescent state [14]. As shown in Figure 2b,c, ectopic
expression of any of the Cdk inhibitors was sufficient to
induce positive staining for SA-β-gal activity, although with
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Figure 2
Expression of senescence markers in human
diploid fibroblasts expressing Cdk inhibitors.
(a) Total RNA was isolated from senescent
cells or cells 6 days after infection either with
a retrovirus encoding the indicated Cdk
inhibitor or with the empty vector control
(Vector) and 8 µg of each sample was
separated by electrophoresis, blotted and
hybridised with a PAI-1 cDNA probe.
Transcript levels determined by
phosphorimaging analysis were normalised to
glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) levels. (b) Cells were assayed for
SA-β-gal activity in situ as previously
described [14]. The examples shown are cells
expressing vector alone, p16INK4a or p21CIP1
as indicated. Following staining for SA-β-gal
activity, cell nuclei were visualised with
Hoechst 33528 dye (5 µg/ml for 3 min) to
determine the total number of cells in each
field. (c) The proportion of cells expressing
SA-β-gal activity was calculated by observing
~400 cells per sample in three separate
experiments. 
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varying degrees of effectiveness. SA-β-gal activity was
detectable at 9 days post-infection and maximal by day 12.
A higher proportion of cells positive for SA-β-gal was
obtained with the INK4 proteins than with p21CIP1 or
p27KIP1, suggesting that the ability of the Cdk inhibitors to
induce senescence-associated markers was directly related
to the extent to which they reduced cell growth and
blocked entry into S phase. Significantly, co-infecting cells
using retroviruses encoding p16INK4a and p21CIP1 with dif-
ferent selectable markers had an additive effect, with a
higher proportion of cells positive for SA-β-gal than with
cells expressing either inhibitor on its own (Figure 2c).
These results strongly suggest that the inhibition of G1
Cdk activity is a critical determinant of several facets of
the senescent phenotype. To confirm this proposition, we
used a 20-residue synthetic peptide corresponding to
amino acids 84–103 of p16INK4a to directly inhibit
Cdk4/Cdk6 activity in young TIG-3 cells. When coupled
to a 16-amino-acid domain from the Drosophila Antenna-
pedia protein, the p16INK4a peptide has been shown to
penetrate biological membranes and to block the ability of
Cdk4 and Cdk6 to phosphorylate pRb [16]. The Antenna-
pedia–p16 peptide (Ant–p16 peptide), tagged with biotin
at its amino terminus, was added to the medium of young
TIG-3 cells at a range of concentrations (0–10 µM).
Immunofluorescence detection of the biotin tag con-
firmed that the peptide was present in all cells (Figure 3a).
As with introduction of the retrovirally expressed Cdk
inhibitors, cells treated with the Ant–p16 peptide had a
significantly slower rate of division whereas control cells
treated with equimolar amounts of p16 and Antennapedia
peptides, synthesised separately and mixed, grew at a
normal rate (data not shown). The Ant–p16 peptide also
inhibited BrdU incorporation in the treated cells in both a
time-dependent and dose-dependent manner (Figure 3b).
When cells were stained for SA-β-gal activity at various
times following addition of the Ant–p16 peptide, the pro-
portion of positive cells again depended on the concentra-
tion of added peptide, with approximately 80% of the cells
staining blue after 6 days in 10 µM peptide (Figure 3c–e).
At these high concentrations, however, there was a ten-
dency for cells to aggregate and detach from the culture
dish, an effect that was not apparent with the separate
Antennapedia and p16 peptides. Nevertheless, these
results imply that the total concentration of Cdk inhibitor
has a direct impact on the completeness of the G1 arrest
and the subsequent expression of senescence markers.
The data we describe here reinforce the proposed connec-
tion between replicative senescence and the Cdk inhibitors
p16INK4a and p21CIP1 by providing the first direct evidence
for their ability to induce senescence-like features in early
passage human diploid fibroblasts. Serrano et al. [15]
recently described analogous phenotypic changes in human
diploid fibroblasts transduced with retroviruses encoding
activated Ras and ascribed the effects to the upregulation of
p53, p21CIP1 and p16INK4a. Similar effects have also been
reported in some cancer cell lines ectopically expressing
p16INK4a alone [18] but the majority of established cell lines
do not respond in this way, raising interesting questions
regarding the difference between the G1 arrest commonly
associated with ectopic expression of Cdk inhibitors and the
panoply of changes induced by Cdk inhibitors in human
diploid fibroblasts. One possibility is that such effects are
only observed in diploid or ‘near-diploid’ cells and that
most tumour cell lines have sustained a sufficient number
of additional mutations to obscure or obviate the effects. 
Another intriguing point is the timescale required to
develop some of the phenotypic characteristics of
senescence. For example, with retroviral delivery of the
inhibitors, SA-β-gal staining was not apparent until 9–10
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Figure 3
Induction of senescence markers using the Ant–p16 peptide. 
(a) TIG-3 cells were treated for 24 h with 10 µM biotinylated Ant–p16
peptide and fixed with methanol/acetone (50:50) for 5 min at –20°C.
Intracellular peptide was visualised using fluorescein-conjugated
streptavidin at a dilution of 1:40. (b) Cells were either left untreated or
treated with 2.5, 5.0, 7.5 or 10 µM Ant–p16 peptide, with fresh
medium and peptide added every second day. On days 1, 3 and 6
after peptide addition, the cells were labelled with 10 µM BrdU for 4 h
and assayed for BrdU incorporation by immunofluorescence. 
(c) Untreated TIG-3 cells and (d) cells treated with 5 µM Ant–p16
peptide for 6 days were assayed in situ for SA-β-gal activity as
described [14]. (e) Cells were either left untreated or incubated with
2.5, 5.0, 7.5 or 10 µM Ant–p16 peptide and the proportion of cells
with SA-β-gal activity was estimated 1, 3 and 6 days after peptide
addition. Each point was calculated from counting 400 cells in two
independent experiments.
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days post-infection as previously noted by Serrano et al.
[15] whereas the changes in cell size and expression of
PAI-1 occurred earlier. Such observations suggest a need
for the accumulation or decay of some intracellular
factor(s). The interpretation of these events, however,
depends on whether the ectopic expression of Cdk
inhibitors caused a generalised slowing of the cell cycle in
all infected cells or whether the variable levels of expres-
sion within the pools of cells caused complete arrest in
some cells but allowed others to cycle normally.
The additive effect of retroviruses encoding p16INK4a and
p21CIP1 could be due to an ability of these inhibitors to
target different cyclin–Cdk complexes or to their different
modes of action. Indeed, Alcorta et al. [7] reported that in
senescent human diploid fibroblasts, most of the
Cdk4/Cdk6 is associated with p16INK4a while the remain-
der is found in complexes with p21CIP1. The most logical
explanation for our results, however, would be that it is
the degree to which Cdk activity can be inhibited that is
critical. Thus, there appears to be a good correlation
between the degree of growth arrest and inhibition of
DNA synthesis observed with different inhibitors and the
extent to which the cells stain positively for SA-β-gal.
Moreover, simply increasing the dose of the Ant–p16
peptide can achieve a more complete arrest and a higher
proportion of SA-β-gal positivity. Nevertheless, as both
p21CIP1 and p16INK4a accumulate in senescent cells, we
favour a model in which both of these Cdk inhibitors are
critical executors of the Hayflick limit [1] and presumably
of a mechanism that acts in vivo to prevent immortalisa-
tion and neoplasia. The data also suggest that features
previously regarded as peculiar to senescent cells can be
reproduced by imposing a sustained G1 arrest in the con-
tinued presence of serum mitogens.
Materials and methods
Cell culture and retroviral infection
TIG-3 cells were cultured in DMEM containing 10% foetal calf serum
and passaged at a 1:4 split ratio. To permit uptake of ecotropic retro-
viruses, cells were infected with an amphotropic retrovirus (pWXL-
Neo-Eco) encoding the mouse basic amino acid transporter, which
serves as the cell surface receptor for mouse ecotropic retroviruses
[15,19], and selected in 200 µg/ml G418. Pools of G418-resistant
cells were infected with ecotropic retroviruses prepared by transient
transfection of BOSC 23 cells with pBABE-puro or pBABE-hygro
vectors [17,20] and selected 48 h post-infection in medium containing
2.5 µg/ml puromycin or 75 µg/ml hygromycin.
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